Aurobindo Pharma reports 41% fall in Q2 consolidated net profit

14 Nov 2022 Evaluate

Aurobindo Pharma has reported results for second quarter ended September 30, 2022.

The company has reported a fall of 16.72% in its net profit at Rs 164.63 crore for the quarter under review as compared to Rs 197.68 crore for the same quarter in the previous year. However, total income of the company increased by 4.94% at Rs 3025.66 crore for Q2FY23 as compared Rs 2883.18 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported fall of 41.10% in its net profit at Rs 410.37 crore for the quarter under review as compared to Rs 696.71 crore for the same quarter in the previous year. Total income of the company decreased by 4.01% at Rs 5796.56 crore for Q2FY23 as compared Rs 6038.50 crore for the corresponding quarter previous year.

Aurobindo Pharma Share Price

1212.30 61.75 (5.37%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×